ArticleDiagnostics (Basel, Switzerland)2023
End-to-End Deep Learning Method for Detection of Invasive Parkinson's Disease.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 27 citations in OpenAlex.
- Neuroprotective effects of ursodeoxycholic acid in Parkinson's disease and Alzheimer's disease.Neuroprotection (Chichester, England) · 2026Review
- Computational Approaches to Neurological Disorder Diagnosis: An In-Depth Review of Current Methods and Future ProspectsCurrent medical imaging · 2026Review
- A Unified Deep Learning Ensemble Framework for Voice-Based Parkinson's Disease Detection and Motor Severity Prediction.Bioengineering (Basel, Switzerland) · 2025Article
- Z/Ce@hemin enzymes with enhanced peroxidase activity for monitoring and screening the oxidative stress models of Parkinson's disease.NPJ Parkinson's disease · 2025Article
- Joint effect of modifiable risk factors on Parkinson's disease: a large-scale longitudinal study.Frontiers in human neuroscience · 2025Article
- Combined with multimodal medical imaging and artificial intelligence for early diagnosis of Parkinson's disease.Frontiers in neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease directly affects the nervous system are causes a change in voice, lower efficiency in daily routine tasks, failure of organs, and death. As an estimate, nearly ten million people are suffering from Parkinson's disease worldwide, and this number is increasing day by day. The main cause of an increase in Parkinson's disease patients is the unavailability of reliable procedures for diagnosing Parkinson's disease. In the literature, we observed different methods for diagnosing Parkinson's disease such as gait movement, voice signals, and handwriting tests. The detection of Parkinson's disease is a difficult task because the important features that can help in detecting Parkinson's disease are unknown. Our aim in this study is to extract those essential voice features which play a vital role in detecting Parkinson's disease and develop a reliable model which can diagnose Parkinson's disease at its early stages. Early diagnostic systems for the detection of Parkinson's disease are needed to diagnose Parkinson's disease early so that it can be controlled at the initial stages, but existing models have limitations that can lead to the misdiagnosing of the disease. Our proposed model can assist practitioners in continuously monitoring the Parkinson's disease rating scale, known as the Total Unified Parkinson's Disease Scale, which can help practitioners in treating their patients. The proposed model can detect Parkinson's disease with an error of 0.10 RMSE, which is lower than that of existing models. The proposed model has the capability to extract vital voice features which can help detect Parkinson's disease in its early stages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.